Despite heightened activity of AIM2 in T2D, AIM2‐mediated IL‐18 plays a protective role in the progression of streptozotocin‐induced T1D by mitigating alterations in gut microbiota and reinforcing intestinal barrier function121 (Figure 4C). Here, AIM2 is linked to type 2 diabetes mellitus.